BioHarvest Sciences, Inc. (BHST) Net Sales Margin

Brandmark of BioHarvest Sciences, Inc. (BHST)

BioHarvest Sciences operates in the highly competitive niche of plant-based component biosynthesis, where large chemical behemoths exert significant pressure. The net profit margin provided by GURU.Markets data reflects the current efficiency momentum, with the current mark standing at -34.70. The business is protected by unique patents for its IT platform under strict FDA supervision, while the scalability of bioreactors ensures a substantial reduction in operating expenses.

BioHarvest Sciences (BHST) - Net Sales Margin from 11/13/2024 to 11/19/2026

Financial and market metric breakdowns for BioHarvest (BHST)

- market value and analyst target forecast:
Comprehensive company analysis:BioHarvest Sciences
Finished products of BioHarvest Sciences, Inc.

Sales margin measures the share of net profit in every dollar of revenue, reflecting the efficiency of operating expense management and the ultimate profitability of the business. For BioHarvest Sciences (BHST), this metric demonstrates the extent to which bioreactor automation reduces production costs, allowing investors to assess the actual scalability of the model through the history of net profit margins.

Competitors of BioHarvest Sciences (BHST)

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma